OncoVista, Inc. Report issue

For profit Phase 2
Founded: San Antonio TX United States (2004)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2008
NCT00709215
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

cordycepin (1 trial)

pentostatin (nipent) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2